Author(s)

Johanna Lönn, Faisal Shahzad, Fredrik Uhlin, Torbjörn Bengtsson, Gabriel Almroth, Fariba Nayeri

Department of Molecular and Clinical Medicine, Division of Infectious Diseases, University Hospital, Link?ping, Sweden.
Department of Nephrology UHL, County Council of ?sterg?tland, Department of Medicine and Health Science, Faculty of Health Science, Link?ping University, Link?ping, Sweden.
Division of Clinical Medicine, School of Health and Medical Sciences, ?rebro University, ?rebro, Sweden.
PEAS Institute, Link?ping, Sweden.

Hepatocyte growth factor (HGF) is a renotropic, antifibrotic and regenerative factor with cytoprotective effects that is produced by mesenchymal cells and shows high affinity to components of extra cellular matrix, such as heparan sulphate proteoglycan (HS-PG), in healthy. Patients with chronic renal failure (CRF) suffer from a chronic inflammatory disorder. In order to assess the underlying mechanisms for development of CRF we aimed to assess the amounts and affinity of HGF in this patient group. Elisa, western blot and surface plasmon resonance (SPR) were used to study HGF in blood samples, as well as in isolated neutrophils, in CRF patients compared to healthy controls. Patients with CRF showed higher HGF levels in serum (P < 0.0001), but decreased affinity to HSPG (P < 0.0001), compared to healthy controls. Addition of protease inhibitors decreased the difference between patients with CRF compared to healthy individuals. HGF with potent regenerative function during injury lacks affinity to HSPG in patients with CRF that may depend on production of proteases from activated immune cells. This information might be used to highlight underlying mechanisms for chronicity and leading to new strategies for treatment of chronic injuries.

Chronic Renal Failure; Hepatocyte Growth Factor; Biological Activity; Neutrophils

Lönn, J. , Shahzad, F. , Uhlin, F. , Bengtsson, T. , Almroth, G. and Nayeri, F. (2012) High concentration but low biological activity of hepatocyte growth factor in patients with chronic renal failure. Advances in Bioscience and Biotechnology, 3, 516-523. doi: 10.4236/abb.2012.324068.